GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Control Bionics Ltd (ASX:CBL) » Definitions » Current Deferred Taxes Liabilities

Control Bionics (ASX:CBL) Current Deferred Taxes Liabilities : A$0.00 Mil (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Control Bionics Current Deferred Taxes Liabilities?

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

Control Bionics's current deferred tax liabilities for the quarter that ended in Dec. 2023 was A$0.00 Mil.

Control Bionics Current Deferred Taxes Liabilities Historical Data

The historical data trend for Control Bionics's Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Control Bionics Current Deferred Taxes Liabilities Chart

Control Bionics Annual Data
Trend Jun20 Jun21 Jun22 Jun23
Current Deferred Taxes Liabilities
- - - -

Control Bionics Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Current Deferred Taxes Liabilities Get a 7-Day Free Trial - - - - -

Control Bionics Current Deferred Taxes Liabilities Related Terms

Thank you for viewing the detailed overview of Control Bionics's Current Deferred Taxes Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Control Bionics (ASX:CBL) Business Description

Traded in Other Exchanges
N/A
Address
697 Bourke Road, Suite 5.01, Camberwell, Melbourne, VIC, AUS, 3124
Control Bionics Ltd is engaged in the business of healthcare devices. It is engaged in the development, commercialization, and sale of assistive communications technology systems within the disability sector. Its core systems include NeuroNode Trilogy and NeuroNode3. These systems allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. Geographically it derives a majority of revenue from North America and has its presence in Australia as well.